{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:42:38Z","timestamp":1783028558878,"version":"3.54.6"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1053\/j.seminoncol.2016.02.020","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T22:20:31Z","timestamp":1456352431000},"page":"359-365","source":"Crossref","is-referenced-by-count":23,"title":["Cutaneous manifestations in leukemia patients"],"prefix":"10.1053","volume":"43","author":[{"given":"Michael R.","family":"Grunwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan H.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghava","family":"Induru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2016.02.020_bib1","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1309\/WYACYWF6NGM3WBRT","article-title":"Leukemia cutis","volume":"129","author":"Cho-Vega","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ajcp\/100.3.276","article-title":"Leukemia cutis. Analysis of 50 biopsy-proven cases with an emphasis on occurrence in myelodysplastic syndromes","volume":"100","author":"Longacre","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00277-001-0412-9","article-title":"A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis","volume":"81","author":"Agis","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(197304)31:4<948::AID-CNCR2820310428>3.0.CO;2-N","article-title":"Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949-1969","volume":"31","author":"Liu","year":"1973","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G","article-title":"Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.V35.3.361.361","article-title":"Granulocytic sarcoma (chloroma)","volume":"35","author":"Wiernik","year":"1970","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib8","first-page":"27","article-title":"Leukemia cutis\u2014epidemiology, clinical presentation, and differential diagnoses","volume":"10","author":"Wagner","year":"2012","journal-title":"J Deutsch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3346\/jkms.2013.28.4.614","article-title":"Clinical characteristics of 75 patients with leukemia cutis","volume":"28","author":"Kang","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0190-9622(99)70086-1","article-title":"Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria","volume":"40","author":"Kaddu","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.V55.1.71.71","article-title":"Acute monoblastic leukemia: a clinical and biologic study of 74 cases","volume":"55","author":"Tobelem","year":"1980","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2230.2005.02022.x","article-title":"Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis","volume":"31","author":"Watson","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1365-2133.2000.03774.x","article-title":"Leukaemia cutis and leukaemic vasculitis","volume":"143","author":"Paydas","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5021\/ad.2009.21.2.193","article-title":"A case of leukemia cutis at the site of a prior catheter insertion","volume":"21","author":"Lee","year":"2009","journal-title":"Ann Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1346-8138.2010.00823.x","article-title":"Leukemia cutis limited to the needle puncture sites","volume":"37","author":"Kim","year":"2010","journal-title":"J Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib16","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/1097-0142(19861215)58:12<2697::AID-CNCR2820581225>3.0.CO;2-R","article-title":"Granulocytic sarcoma in nonleukemic patients","volume":"58","author":"Meis","year":"1986","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D36W07C9WZ","article-title":"Post-bone-marrow-transplant leukemia cutis","volume":"19","author":"Pulgar","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-4632.2011.05297.x","article-title":"Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis","volume":"51","author":"Patel","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.1993.11.4.690","article-title":"Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia","volume":"11","author":"Tallman","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib20","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/1097-0142(19890601)63:11<2192::AID-CNCR2820631122>3.0.CO;2-R","article-title":"Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986","volume":"63","author":"Baer","year":"1989","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00019606-200012000-00003","article-title":"Increased incidence of trisomy 8 in acute myeloid leukemia with skin infiltration (leukemia cutis)","volume":"9","author":"Sen","year":"2000","journal-title":"Diagn Mol Pathol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib22","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.leu.2404699","article-title":"Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas","volume":"21","author":"Falini","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","article-title":"FLT3 mutations in myeloid sarcoma","volume":"126","author":"Ansari-Lari","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.6004\/jnccn.2012.0120","article-title":"Management of extramedullary leukemia as a presentation of acute myeloid leukemia","volume":"10","author":"Slomowitz","year":"2012","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10245330600702893","article-title":"t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience","volume":"11","author":"Ruiz-Arguelles","year":"2006","journal-title":"Hematology"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461","volume":"15","author":"Byrd","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib27","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1200\/JCO.2007.15.6315","article-title":"Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC","volume":"26","author":"Chevallier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib29","first-page":"801","article-title":"Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation","volume":"17","author":"Bekassy","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib30","first-page":"223","article-title":"Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis","volume":"13","author":"Su","year":"1994","journal-title":"Semin Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anai.2009.11.006","article-title":"Current approaches to the diagnosis and treatment of systemic mastocytosis","volume":"104","author":"Bains","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0889-8588(05)70296-3","article-title":"Hematologic aspects of systemic mastocytosis","volume":"14","author":"Parker","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1468-3083.2007.02520.x","article-title":"Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients","volume":"22","author":"Dalamaga","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2003.09.020","article-title":"Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations","volume":"40","author":"Kaplan","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1008324929876","article-title":"Paraneoplastic pemphigus as the initial presentation of chronic lymphocytic leukemia","volume":"12","author":"van Mook","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib36","first-page":"207126","article-title":"Paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome or autoimmune multiorganopathy?","volume":"2012","author":"Mahajan","year":"2012","journal-title":"Case Rep Dermatol Med"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0030-4220(93)90095-L","article-title":"Paraneoplastic pemphigus. A distinct autoimmune vesiculobullous disorder associated with neoplasia","volume":"75","author":"Helm","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib38","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/ajh.23471","article-title":"A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma","volume":"88","author":"Moustafa","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4103\/0970-9290.138358","article-title":"Sweet\u2019s syndrome","volume":"25","author":"Limdiwala","year":"2014","journal-title":"Ind J Dental Res"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/pgmj.73.856.65","article-title":"Neutrophilic dermatoses: pyoderma gangrenosum and Sweet\u2019s syndrome","volume":"73","author":"Lear","year":"1997","journal-title":"Postgrad Med J"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10156-003-0254-6","article-title":"Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndrome","volume":"9","author":"Yamauchi","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2013.06.023","article-title":"Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients","volume":"69","author":"Rochet","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4274\/Tjh.2012.0055","article-title":"Sweet syndrome in a patient with chronic lymphocytic leukemia\/small lymphocytic lymphoma: curious lymphocyte\/neutrophil fluctuations","volume":"30","author":"Usul Afsar","year":"2013","journal-title":"Turk J Haematol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clml.2014.12.009","article-title":"Characteristics of Sweet syndrome in patients with acute myeloid leukemia","volume":"15","author":"Kazmi","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib46","doi-asserted-by":"crossref","first-page":"823286","DOI":"10.1155\/2014\/823286","article-title":"A case report of hairy cell leukemia presenting concomitantly with sweet syndrome","volume":"2014","author":"Alkayem","year":"2014","journal-title":"Case Rep Med"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib47","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mjd.2001.112377","article-title":"Pyoderma gangrenosum associated with biphenotypic acute leukemia","volume":"44","author":"Asai","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000018360","article-title":"Pyoderma gangrenosum as an early revelator of acute leukemia","volume":"200","author":"Beele","year":"2000","journal-title":"Dermatology"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1346-8138.2003.tb00334.x","article-title":"Bullous pyoderma gangrenosum complicated by disseminated intravascular coagulation with subsequent myelodysplastic syndrome (chronic myelomonocytic leukemia)","volume":"30","author":"Rogalski","year":"2003","journal-title":"J Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MD.0000000000000009","article-title":"The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features","volume":"92","author":"Loricera","year":"2013","journal-title":"Medicine"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib51","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1468-3083.2010.03614.x","article-title":"Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome","volume":"24","author":"Farah","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib52","first-page":"835","article-title":"Skin erythema with leukocytoclastic vasculitis and elastophagocytosis as the presenting features of an underlying myelodysplastic syndrome","volume":"7","author":"Ishida","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D37111D8SJ","article-title":"Cutaneous granulomatous vasculitis associated with chronic lymphocytic leukemia: case report and review of literature of a rare entity","volume":"18","author":"Gaertner","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib54","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11926-014-0420-0","article-title":"Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach","volume":"16","author":"Perez-Alamino","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2169\/internalmedicine.46.1712","article-title":"Acquired ichthyosis disclosing non-Hodgkin\u2019s malignant lymphoma","volume":"46","author":"Rabhi","year":"2007","journal-title":"Intern Med"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.annder.2011.10.394","article-title":"[Acquired ichthyosis and haematological malignancies: five cases]","volume":"139","author":"Berrady","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib57","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.bmt.1701240","article-title":"Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia","volume":"21","author":"Dilek","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0190-9622(96)90489-2","article-title":"Acquired ichthyosis in bone marrow transplant recipients","volume":"35","author":"Spelman","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.amjmed.2013.12.009","article-title":"Beware of underlying malignancy: acquired ichthyosis","volume":"127","author":"Word","year":"2014","journal-title":"Am J Med"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib60","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1529-8019.2010.01366.x","article-title":"Chronic pruritus: a paraneoplastic sign","volume":"23","author":"Yosipovitch","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib61","first-page":"557","article-title":"Research in practice: substance P antagonism in chronic pruritus","volume":"12","author":"Lotts","year":"2014","journal-title":"J Deutsch Dermatol Gesellschaft"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib62","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","article-title":"Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy","volume":"5","author":"Stander","year":"2010","journal-title":"PloS One"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib63","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","article-title":"Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial","volume":"19","author":"Gunal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib64","first-page":"86","article-title":"Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation","volume":"18","author":"Manenti","year":"2005","journal-title":"J Nephrol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib65","first-page":"398769","article-title":"Concurrent presentation of Hodgkin lymphoma and multiple myeloma","volume":"2013","author":"Chandran","year":"2013","journal-title":"Case Rep Hematol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib66","first-page":"535","article-title":"[Cytarabine and skin reactions in acute myeloid leukemia]","volume":"73","author":"Grille","year":"2013","journal-title":"Medicina"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy","volume":"40","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib68","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1468-3083.2002.00395.x","article-title":"High-dose cytosine arabinoside-induced cutaneous reactions","volume":"16","author":"Cetkovska","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/archderm.1990.01670250079013","article-title":"Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of \u2019chemotherapy-associated eccrine hidradenitis\u2019 and \u2019neutrophilic eccrine hidradenitis\u2019","volume":"126","author":"Hurt","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib70","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0190-9622(93)70090-G","article-title":"Neutrophilic eccrine hidradenitis","volume":"28","author":"Thorisdottir","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib71","series-title":"Dermatology in general medicine","first-page":"1800","article-title":"Mucocutaneous complications of anti-neoplastic therapy","author":"Yokel","year":"1993"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib72","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0190-9622(99)70455-X","article-title":"Chemotherapy-induced inflammation in seborrheic keratoses mimicking disseminated herpes zoster","volume":"40","author":"Williams","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib73","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0190-9622(08)80126-0","article-title":"Treatment of cytarabine acral erythema with corticosteroids","volume":"24","author":"Brown","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib74","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00280-004-0858-2","article-title":"Particular cutaneous side effects with etoposide-containing courses: is VP16 or etoposide phosphate responsible?","volume":"55","author":"Marigny","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib75","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1182\/blood.V69.4.1015.1015","article-title":"Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplant in patients with advanced hematologic malignancies","volume":"69","author":"Blume","year":"1987","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib76","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1182\/blood.V72.5.1567.1567","article-title":"Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplant in advanced leukemias","volume":"72","author":"Schmitz","year":"1988","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib77","first-page":"83","article-title":"Bone marrow transplant for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide","volume":"5","author":"Bostrom","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib78","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/1097-0142(19930515)71:10<3153::AID-CNCR2820711042>3.0.CO;2-#","article-title":"Dose-related cutaneous toxicities with etoposide","volume":"71","author":"Murphy","year":"1993","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib79","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00280-014-2504-y","article-title":"Enhanced skin toxicity associated with the combination of clofarabine plus cytarabine for the treatment of acute leukemia","volume":"74","author":"Zhang","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib80","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1002\/cncr.25262","article-title":"A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients","volume":"116","author":"von Gruenigen","year":"2010","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib81","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1200\/JCO.2010.29.1807","article-title":"Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study","volume":"28","author":"Kang","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib82","first-page":"268","article-title":"Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding","volume":"9","author":"Latif","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib83","first-page":"334","article-title":"Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma","volume":"46","author":"Sil","year":"2014","journal-title":"Ind J Parmacol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib84","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaad.2008.06.034","article-title":"Dermatologic symptoms associated with the multikinase inhibitor sorafenib","volume":"60","author":"Robert","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00128071-200607010-00004","article-title":"Cutaneous fungal infections in the oncology patient: recognition and management","volume":"7","author":"Mays","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib86","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2014.113399","article-title":"Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study)","volume":"100","author":"Caira","year":"2015","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib87","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2014-04-516211","article-title":"How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach","volume":"124","author":"Nucci","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib88","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10096-014-2277-6","article-title":"Ecthyma gangrenosum and ecthyma-like lesions: review article","volume":"34","author":"Vaiman","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib89","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","article-title":"Infections caused by viridans streptococci in patients with neutropenia","volume":"34","author":"Tunkel","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2016.02.020_bib90","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9343(94)90009-4","article-title":"Bacteremia due to viridans streptococci in neutropenic patients: a review","volume":"97","author":"Bochud","year":"1994","journal-title":"Am J Med"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T15:44:53Z","timestamp":1718379893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775416000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0093775416000452"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.02.020","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}